Literature DB >> 11884583

Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency.

Hitoshi Sato1, Lesley Pesnicak, Jeffrey I Cohen.   

Abstract

Varicella-zoster virus (VZV) encodes six genes that do not have homologs in herpes simplex virus. One of these genes, VZV open reading frame 2 (ORF2), was expressed as a 31-kDa phosphoprotein in the membranes of infected cells. Unlike equine and bovine herpesvirus type 1 ORF2 homologs that are associated with virions, VZV virions contained no detectable ORF2 protein. The ORF2 deletion mutant established a latent infection in cotton rats at a frequency and with a number of VZV genomes similar to that of the parental virus. ORF63 transcripts, a hallmark of latent infection, were present in ganglia latently infected with both the ORF2 deletion mutant and parental VZV. Thus, ORF2 is the first VZV gene shown to be dispensable for establishment of latent infection in an animal model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884583      PMCID: PMC136057          DOI: 10.1128/jvi.76.7.3575-3578.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

Review 1.  A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24.

Authors:  Y Izumiya; H K Jang; M Ono; T Mikami
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; S Bontems; C Sadzot-Delvaux
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

3.  The DNA sequence of the simian varicella virus genome.

Authors:  W L Gray; B Starnes; M W White; R Mahalingam
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

4.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 6.  Viral disease models in primates.

Authors:  K F Soike; S R Rangan; P J Gerone
Journal:  Adv Vet Sci Comp Med       Date:  1984

7.  Viral gene expression in rat trigeminal ganglia following neonatal infection with varicella-zoster virus.

Authors:  P A Brunell; L C Ren; J I Cohen; S E Straus
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

8.  Evidence of latent varicella-zoster virus in rat dorsal root ganglia.

Authors:  P Annunziato; P LaRussa; P Lee; S Steinberg; O Lungu; A A Gershon; S Silverstein
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells.

Authors:  G W Kemble; P Annunziato; O Lungu; R E Winter; T A Cha; S J Silverstein; R R Spaete
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture.

Authors:  E Cox; S Reddy; I Iofin; J I Cohen
Journal:  Virology       Date:  1998-10-10       Impact factor: 3.513

View more
  30 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  Simian varicella in old world monkeys.

Authors:  Wayne L Gray
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

3.  Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Authors:  Seung-Tae Lee; Paige Bracci; Mi Zhou; Terri Rice; John Wiencke; Margaret Wrensch; Joseph Wiemels
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

4.  Genetic complexity of EHV-1 defective interfering particles and identification of novel IR4/UL5 hybrid proteins produced during persistent infection.

Authors:  Paul D Ebner; Dennis J O'Callaghan
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

5.  Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells.

Authors:  Renée L Finnen; Kara R Mizokami; Bruce W Banfield; Guang-Yun Cai; Scott A Simpson; Lewis I Pizer; Myron J Levin
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 6.  Simian varicella virus: molecular virology.

Authors:  Wayne L Gray
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Varicella-zoster virus infection of human neural cells in vivo.

Authors:  Armin Baiker; Klaus Fabel; Antonio Cozzio; Leigh Zerboni; Konstanze Fabel; Marvin Sommer; Nobuko Uchida; Dongping He; Irving Weissman; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

9.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.